Sign Up for a Free Account
  • Updated 07.03.2023
  • Released 07.17.2000
  • Expires For CME 07.03.2026

Paget disease of bone: neurologic complications



Paget disease of bone is an osteoclastic-mediated disorder of the bone in which abnormal bone resorption and inadequate remodeling leads to mechanically weakened bone. Demonstrating variable geographic prevalence, it is becoming less frequent, and age of onset is lengthening in areas of high prevalence. A combination of genetic and environmental triggers appears to describe its pathophysiology and is helping to clarify other inherited osteolytic disorders of bone and their related cellular processes. In this article, the author provides the recommendations from the PRISM study and PRISM-EZ study with respect to symptomatic versus intensive treatment of Paget disease of bone with bisphosphonates. Concerns over the safety issues with bisphosphonate therapy are also addressed.

Key points

• Paget disease of bone (PDB) is a disorder of bone remodeling where abnormal bone resorption and inadequate remodeling results in mechanically weakened bone.

• Paget disease of bone is asymptomatic in over 70% of individuals and often identified incidentally by an elevated serum alkaline phosphatase or screening plain films of the abdomen.

• Paget disease of bone demonstrates variable geographic prevalence, highest in Northwestern Europe, but is becoming less frequent in areas of once-high prevalence that predate current treatments.

• Neurologic syndromes of Paget disease of bone result from the close relationship between the skeletal and nervous system, and although direct compression explains most observed syndromes, vascular steal phenomena may also play a role.

• The primary intervention for Paget disease of bone is bisphosphonate treatment, after calcium and vitamin D deficiencies are corrected; zoledronate may be the treatment of first choice.

Historical note and terminology

Although Wilks described the disorder in 1869 (81), Sir James Paget’s publication of a necropsy report as a form of “chronic inflammation of the bones” (osteitis deformans) provided the first thorough description of the disorder (50); by 1889 the disorder was officially associated with Paget when the eponym, Paget disease of bone (PDB), was added to the Oxford English Dictionary. In his original report, Paget described a man who presented with thigh pain and tibial deformity and died 22 years later from a malignant tumor of the radius (09). Paget later published additional cases that with his original report identified many of the clinical and pathological features we now recognize (51). However, his suggestion of an inflammatory etiology has not been shown to be true.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125